An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
301
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive ...
Jul 28, 2022
0
5
A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
Jul 26, 2022
0
6
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease caused by progressive scarring of the lungs, leading to respiratory failure and death. Therapies to treat IPF are limited, making studies on the mechanisms ...
Jul 25, 2022
0
91
While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after initial infection.
Jul 20, 2022
0
102
A promising avenue of research into chronic lung disease treatment has hit a speed bump, with a new study showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea hoped for by researchers.
Jun 6, 2022
0
16
A new analysis of data from the Veterans Affairs Million Veteran Program has uncovered genetic links between COVID-19 severity and certain medical conditions that are known risk factors for severe COVID-19. Anurag Verma of ...
Apr 28, 2022
0
163
Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that protects older people against aspects of aging and a range of diseases. Their findings, which are published in eBioMedicine, demonstrate ...
Mar 15, 2022
0
90
Investigators studying lung cells have discovered that the normal repair process that occurs after lung disease or injury appears to be incomplete but still ongoing in patients who died of COVID-19 and non-COVID acute respiratory ...
Feb 16, 2022
0
49
Researchers have discovered new insights about lymphangioleiomyomatosis (LAM), a rare lung disease, which affects about 1 in 200,000 Americans and commonly features the growth of abnormal cells in different tissues and organs, ...
Feb 2, 2022
0
13
